Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions-Reference-Cited by-同舟云学术

Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions

Published:2023-03-01 Issue:3 Volume:9 Page:434
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Rassy Elie¹,Le Roy Florence¹²,Smolenschi Cristina¹,Valéry Marine¹,Boige Valérie¹,Ducreux Michel¹³,Boilève Alice¹³

Affiliation:

1. Département de Médecine Oncologique, Gustave Roussy, Villejuif, France

2. Service de Gastroentérologie, Groupe Hospitalier Bretagne Sud, Hôpital du Scorff, Lorient, France

3. Faculté de Médecine Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France

Abstract

This cohort study assesses the outcome of oxaliplatin desensitization for patients with gastrointestinal cancers who experienced hypersensitivity reactions after oxaliplatin infusion.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2800950/jamaoncology_rassy_2023_ld_220033_1678387736.10054.pdf

Reference6 articles.

1. Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer.;Seki;Int J Med Sci,2011

2. Hypersensitivity reactions related to oxaliplatin (OHP).;Brandi;Br J Cancer,2003

3. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.;Lee;Ann Allergy Asthma Immunol,2009

4. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.;Hong;J Allergy Clin Immunol Pract,2014

5. Effectiveness of oxaliplatin desensitization protocols.;Cortijo-Cascajares;Clin Transl Oncol,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin desensitization for ovarian cancer in pregnancy: A case report;Gynecologic Oncology Reports;2024-04

2. High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy;International Immunopharmacology;2024-03

3. Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer;Journal of Oncology Pharmacy Practice;2023-12-12